Bob Bollinger, MD, MPH

Role:

Director

Professor of Medicine, Professor of Public Health, Professor of Nursing

Dr. Bollinger is Founding Director of the Center for Clinical Global Health Education (CCGHE) and Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine. He holds joint appointments in international health at the Johns Hopkins (JH) Bloomberg School of Public Health, and in community public health at the JH School of Nursing. He is Associate Director for Medicine of the JH Center for Global Health, Director of the JHU Fogarty India Program, and course instructor for the Global Health Intersession Course for JH medical students, which links medical students and faculty around the globe, and Director of the newly formed IMEC-JHU Partnership to advance applications in healthcare, combining JH clinical and research expertise with IMEC nanoelectronic capabilities. He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases.

Dr. Bollinger has more than 35 years of experience in international public health, clinical research, and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections and other emerging diseases. His research interests include identifying biological and behavioral risk factors for HIV transmission; characterizing the clinical progression and treatment of HIV and related infections; and implementing science research projects to optimize healthcare capacity and delivery in resource-limited settings. He has been invited to participate in public health training programs and expert committees, and has been consulted for his expertise by more than 15 countries. He served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), and a member of the PACHA International Sub-committee, and is a current member of the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety. Working with partners in more than 20 countries, Dr. Bollinger and CCGHE faculty pioneered the development and use of distance learning and their award-winning mobile health platform (emocha^®) in resource-limited settings (www.emocha.com).

Dr. Bollinger is committed to improving the health of people living in resource-limited nations through clinical research, education, and leadership training. He established and has sustained programs in countries throughout Africa, South and Central America, Southeast Asia, and the Middle East. He currently leads the JHU team providing technical support to the Medical Education Partnership Initiative (MEPI) in Uganda, where he has worked for more than 15 years. In 1991, he initiated an ongoing, NIH-funded Indo-US HIV research program in Pune, India, involving the National AIDS Research Institute/ICMR and the BJ Medical College. He has served as Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which changed World Health Organization (WHO) guidelines for treatment of infants born to HIV/positive mothers to prevent mother-to-child transmission. Under his leadership of the Hopkins Fogarty International Program, short-term and degree training has been provided to more than 100 visiting scientists at JHU, and in-country training has been provided to more than 2000 Indian scientists. His commitment to clinician education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award

Dr. Bollinger is author of more than 180 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision.>

Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Master of Public Health from JH Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at JHU School of Medicine.

Studies/Projects
Publications
Presentations
Scholars
Memberships
News

Gut Microbiota of HIV Infected Pregnant Women

Post Date:

2018-06-14

Clinical Sites:

BJGMC

Countries:

India

Birth Outcomes in HIV Both antiretroviral-therapy (ART)-naïve and ART-experienced HIV-infected pregnant women have higher incidences of pre-term birth (PTB) compared to HIV-uninfected women. For example, the global prevalence of PTB is around 8%, while the rates in in HIV-infected populations are...

Optimal Approach for TB Screening among HIV Infected Indian Children

Post Date:

2018-06-11

Clinical Sites:

BJGMC

Countries:

India

Determining TB status (ie, uninfected, latent, and active TB disease) is more difficult among children, particularly HIV-infected children. Diagnosis of TB disease is more difficult among HIV infected children because the signs and symptoms of the disease—such as weight loss, cough, and mild fever—...

Assessing the Impact of the Fogarty HIV-TB Training Program at the Byramjee Jeejeebhoy Government Medical College, Pune, India

Post Date:

2018-01-19

Clinical Sites:

BJGMC

Countries:

India

Johns Hopkins University was funded in 2013 to establish a new post-doctoral training program in HIV-TB epidemiology, clinical and laboratory research, for junior faculty of the Byramjee Jeejeebhoy Government Medical College (BJGMC) in Pune, India, called the BJGMC-JHU Fogarty HIV-TB Training...

Perceptions of HCWs on Barriers and Opportunities to Airborne Infection Control Guideline Implementation

Post Date:

2017-12-07

Clinical Sites:

BJGMC

Countries:

India

Led by Dr. Nishi Suryavanshi, this qualitative, cross-sectional study is assessing healthcare worker (HCW) perceptions about barriers and facilitators to the uptake of airborne infection control (AIC) guidelines. Further, the study is assessing the potential barriers and opportunities to develop...

The Role of GeneXpert in Bacterial Diagnosis of Spinal Tuberculosis

Post Date:

2017-10-26

Clinical Sites:

BJGMC

Countries:

India

India has the maximum burden of tuberculosis (TB) in the world. In 2014, there were an estimated 9.6 million incident cases of TB (range, 9.1 million–10.0 million) globally, equivalent to 133 cases per 100000 population. Most of the estimated number of cases in 2014 occurred in Asia (58%) and the...

Zika Surveillance among Antenatal Clinic Outpatients in BJ Government Medical College and Sassoon General Hospitals, Pune, India

Post Date:

2017-08-31

Clinical Sites:

BJGMC

Countries:

India

CCGHE is keeping an eye on Zika among pregnant women, which is transmitted by mosquitoes & can cause devastating birth defects.

Risk Factors for Unfavourable Treatment Outcomes among Multidrug-Resistant Tuberculosis Patients in Public Sector Treatment in Pune

Post Date:

2017-03-29

Countries:

India

This Fogarty funded study seeks to identify risk factors associated with unfavourable treatment outcomes (death, treatment failure, default, XDR-TB) among multidrug-resistant tuberculosis (MDR-TB) patients under public sector Directly Observed Treatment Short-course (DOTS) Plus in Pune, India...

TREAT Asia: Prevalence and Risk Factors for Oral Cancer among HIV-Infected Adults

Post Date:

2016-12-13

Clinical Sites:

BJGMC

Countries:

India

The study is designed as a cross-sectional, single time point study for opportunistic oral cancer screening of HIV-infected and non- HIV adults 21 years or older in an urban hospital. All participants will undergo screening for oral cancer and oral potentially malignant disorders (OPMD) by visual...

Cost-effectiveness of Xpert MTB/RIF for Diagnosing Pulmonary Tuberculosis in HIV-positive Patients

Post Date:

2016-12-01

Clinical Sites:

BJGMC

Countries:

India

This is a prospective cross-sectional study which will be conducted at BJGMC in Pune, India. The aim of this study is to see whether Xpert MTB/RIF is useful for early detection of pulmonary tuberculosis, and therefore cost-effective, as compared with sputum microscopy and the gold standard tests...

The Evaluation of Clinical Profile and Mortality of Children Admitted with Tuberculosis in Pediatric Intensive-Care Unit at Sassoon General Hospitals, Pune

Post Date:

2016-10-27

Clinical Sites:

BJGMC

Countries:

India

Tuberculosis (TB) is one of the most common causes of infection-related death globally. TB was declared global public health emergency in 1993 by World HealthOrganization (WHO). Mortality due to TB is increasing due to emergence of multidrug resistant (MDR) strains and HIV-TB co-infection,...

ART Study 1: Database: Epidemiology of HIV/AIDS and Associated Comorbidities in a Public Antiretroviral Treatment (ART) Clinic at BJGMC in Pune

Post Date:

2016-09-19

Clinical Sites:

BJGMC

Countries:

India

Since 2004, the National AIDS Control Program of India has been rolling out free antiretroviral therapy. Byramjee Jeejeebhoy Government Medical College (BJGMC), located in Pune, India, is now the largest HIV clinic in India, with over 26,000 adult and pediatric patients registered since 2005. We...

Adherence to Indian National Guidelines for Isoniazid Chemoprophylaxis among Pediatric Contacts of Pulmonary Tuberculosis Cases

Post Date:

2016-07-06

Clinical Sites:

BJGMC

Countries:

India

The primary objective of the study was to assess the implementation of the Indian Revised National Tuberculosis Programme's (RNTCP) guidelines regarding isoniazid preventive treatment (IPT) for children under 6 years of age who had been in contact with adults diagnosed with sputum positive...

A Randomized Therapeutic Interventional Comparative Study between Three Different Modalities of Paediatric Antitubercular Treatment

Post Date:

2016-06-13

Clinical Sites:

BJGMC

Countries:

India

This study, conducted and concluded in 2013, evaluated three different TB treatment regimens in children attending Sassoon General Hospital in Pune, India. A convenience sample size of n=100 children were enrolled in the study. The study investigators in India have asked the JHU faculty listed on...

Optimal Algorithmic Diagnosis of Genital TB among HIV-infected and Uninfected Infertile Women

Post Date:

2016-05-26

Clinical Sites:

BJGMC

Countries:

India

There is a lack of a set protocol universally for diagnosis of genital TB, and for Indian hospitals, India's Revised National Tuberculosis Control Program (RNTCP) also does not give guidelines on diagnosis of Genital TB. Detection of Genital TB in the early stages has a good outcome with return of...

Barriers to Early Treatment Initiation in Childhood Tuberculosis in High Incidence Setting

Post Date:

2016-04-21

Clinical Sites:

BJGMC

Countries:

India

Funded by the Fogarty International Center and led by PI Dr. Chhaya Tukaram Valvi, the aim of this study is to evaluate the time to treatment initiation and barriers to early treatment initiation in childhood tuberculosis. TB diagnosis in children is challenging, often overlooked or missed, because...

Barriers to Implementation of Isoniazid Preventive Treatment (IPT) in Pediatric Contacts of Sputum Positive Adults with Tuberculosis

Post Date:

2016-03-24

Clinical Sites:

BJGMC

Countries:

India

Young children infected with M.tuberculosis can rapidly progress to pulmonary and extrapulmonary disease with high rates of mortality and morbidity. Studies worldwide have demonstrated that IPT not only prevents latent and asymptomatic TB from progression to clinical disease, it also effectively...

miDOT (Directly Observed Therapy)

Post Date:

2015-11-01

Designed by Dr. Maunank Shah, the miDOT mobile health application is a video-based Directly Observed Therapy interface that uses the emocha Mobile Health platform to remotely connect patients on long-term tuberculosis therapy with clinicians who are required to witness patients taking medication...

Smallpox Comes Back to Life in Microbe Hunters

Post Date:

2015-10-22

Baltimore, MD—The world may have been declared free of smallpox in 1980, but the eradication campaign was revived Tuesday in a multimedia presentation at the Johns Hopkins Medical Campus. The event featured a screening of the film Microbe Hunters: Smallpox , by the Johns Hopkins Center for Clinical...

RePORT: C-TRIUMPH: Substudy on Residual Respiratory Impairment Following Pulmonary Tuberculosis

Post Date:

2015-09-13

Clinical Sites:

BJGMC

NIRT

Countries:

India

Many TB patients have residual respiratory impairment despite treatment. Such individuals may be at increased risk of chronic lung diseases and disability in the future. Using respiratory questionnaires and lung function tests, the Lung Health Sub-study will evaluate 400 adult TB patients enrolled...

A5290: A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifampin-Based Tuberculosis Treatment versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifabutin-Based Tuberculosis...

Post Date:

2015-07-07

Clinical Sites:

BJGMC

Countries:

India

This study was terminated February 23, 2016. Full Title: A5290, A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifampin-Based Tuberculosis Treatment versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifabutin-Based...

Loss to follow‐up and mortality among HIV‐infected adolescents receiving antiretroviral therapy in Pune, India

Post Date:

2018-06-25

Clinical Sites:

BJGMC

Countries:

India

Publication:

HIV Medicine

Over 6 years, one-third of HIV+ adolescents in this study discontinued medical treatment, indicating a critical need for retention counselling and closer clinical monitoring.

Developing an assessment framework for essential internal medicine subspecialty topics

Post Date:

2018-06-15

Countries:

United States

Publication:

Journal of Graduate Medical Education

Our assessment framework revealed knowledge and practice gaps in tuberculosis diagnosis among internal medicine residents.

Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?

Post Date:

2018-05-22

Clinical Sites:

BJGMC

Countries:

India

Publication:

The International Journal of Tuberculosis and Lung Disease

Authors find that screening contacts of TB patients for pre-DM/DM and linking them to care may mitigate the risk of developing tuberculosis and improve management of diabetes.

Group mentorship model to enhance the efficiency and productivity of PhD research training in Sub-Saharan Africa

Post Date:

2018-05-04

Countries:

Uganda

Publication:

Annals of Global Health

Annals of Global Health : Systems capacity building approach to PhD training allowed strong outputs at lower cost and with relatively few additional mentors to train independent scientists able to conduct original research and mentor others.

Intestinal barrier dysfunction and microbial translocation in HIV-infected pregnant women is associated with preterm birth

Post Date:

2018-03-24

Clinical Sites:

BJGMC

NIRT

Countries:

India

Publication:

Clinical Infectious Diseases

Clinical Infectious Diseases: Select immune markers can identify women at higher risk for pre-term birth in HIV-1-infected populations; modulating gut barrier integrity and microbial translocation may have an effect.

Gender-based violence screening methods preferred by women visiting a public hospital in Pune, India

Post Date:

2018-01-22

Clinical Sites:

BJGMC

Countries:

India

Publication:

BMC Womens Health

BMC Womens Health : In our study, 23% of women reported experiencing gender based violence, and 90% reported they had never been asked about it in the healthcare setting.

Impact of a community health worker HIV treatment and prevention intervention in an HIV hotspot fishing community in Rakai, Uganda (mLAKE): study protocol for a randomized controlled trial

Post Date:

2017-10-23

Countries:

Uganda

Publication:

Trials

Abstract Background: Effective yet practical strategies are needed to increase engagement in HIV treatment and prevention services, particularly in high-HIV-prevalence hotspots. We designed a community-based intervention called "Health Scouts" to promote uptake and adherence to HIV services in a...

Maternal syphilis: An independent risk factor for mother to infant human immunodeficiency virus transmission

Post Date:

2017-06-15

Clinical Sites:

BJGMC

Countries:

India

Publication:

Sexually Transmitted Diseases

Abstract Syphilis is associated with increased human immunodeficiency virus acquisition and sexual transmission; we examined impact on human immunodeficiency virus mother-to-child transmission among mother-infant pairs enrolled in the India Six-Week Extended-Dose Nevirapine study. Maternal syphilis...

Resident doctors' attitudes toward tuberculosis patients

Post Date:

2017-04-15

Clinical Sites:

BJGMC

Countries:

India

Publication:

Indian Journal of Tuberculosis

Background: The attitude of the resident doctors toward tuberculosis (TB) patients can affect their treatment seeking behavior, compliance to treatment as well as reinforce the stigma attached to the disease by the society at large. Aims: To assess the attitudes of resident medical doctors toward...

Efficacy of six-week extended-dose nevirapine varies by infant birth weight with greatest relative efficacy in low birth weight infants

Post Date:

2016-09-30

Clinical Sites:

BJGMC

Countries:

India

Publication:

PLOS One

Low birth weight (LBW), defined by the World Health Organization (WHO) as birth weight less than 2500 g, is a significant public health issue in resource-limited settings, particularly in Sub Saharan Africa and South Asia where the estimated annual incidence is 14% and 28–31%, respectively, and the...

Continued elevation of interleukin-18 and interferon-γ after initiation of antiretroviral therapy and clinical failure in a diverse multicountry human immunodeficiency virus cohort

Post Date:

2016-07-27

Countries:

India

Publication:

Open Forum Infectious Diseases

Background: We assessed immune activation after antiretroviral therapy (ART) initiation to understand clinical failure in diverse settings. Methods: We performed a case-control study in ACTG Prospective Evaluation of Antiretrovirals in Resource-Limited Settings (PEARLS). Cases were defined as...

Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults

Post Date:

2016-07-01

Countries:

India

Publication:

Journal of Infectious Diseases

Background: Both wasting and obesity are associated with inflammation, but the extent to which body weight changes influence inflammation during human immunodeficiency virus infection is unknown. Methods: Among a random virologically suppressed participants of the Prospective Evaluation of...

Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults

Post Date:

2016-04-01

Clinical Sites:

Countries:

Publication:

The Journal of Infectious Diseases

Persistently elevated C-reactive protein level in the first year of antiretroviral therapy, despite virologic suppression, is associated with HIV disease progression in resource-constrained settings

Post Date:

2016-04-01

Clinical Sites:

Countries:

Publication:

The Journal of Infectious Diseases

A case-cohort analysis of human immunodeficiency virus (HIV)-infected individuals receiving antiretroviral therapy (ART) was performed within a multicountry randomized trial (PEARLS) to assess the prevalence of persistently elevated C-reactive protein (CRP) levels, based on serial measurements of...

High tuberculosis risk among medical trainees, Pune, India

Post Date:

2016-03-22

Clinical Sites:

BJGMC

Countries:

India

Publication:

Emerging Infectious Diseases

During 2012–2013, at a public hospital in Pune, India, 26 (3.9%) cases of tuberculosis were reported among 662 medical trainees, representing an estimated incidence of 3,279 cases/100,000 person-years. Three of these infections were isoniazid-resistant, 1 was multidrug-resistant, and 1 occurred in...

Ecological momentary assessment of illicit drug use compared to biological and self-reported methods

Post Date:

2016-03-15

Countries:

United States

Publication:

Journal of Medical Internet Research

Background: The use of mHealth methods for capturing illicit drug use and associated behaviors have become more widely used in research settings, yet there is little research as to how valid these methods are compared to known measures of capturing and quantifying drug use. Objective: We examined...

Soluble CD14: An independent biomarker for risk of HIV mother-to-child transmission in setting of pre- and post-exposure antiretroviral prophylaxis

Post Date:

2015-10-06

Clinical Sites:

Countries:

Publication:

The Journal of Infectious Diseases

Elevated soluble CD14 (sCD14) concentrations, a marker of monocyte activation, predicts adverse outcomes in human immunodeficiency virus (HIV)-infected adults. To examine the association of sCD14 concentrations with the risk of mother-to-child transmission (MTCT) of HIV, we nested a case-control...

Pre-cART elevation of CRP and CD4+ T-cell immune activation associated with HIV clinical progression in a multinational case-cohort study

Post Date:

2015-10-01

Clinical Sites:

Countries:

Publication:

Journal of Acquired Immune Deficiency Syndromes

Background: Despite the success of combination antiretroviral therapy (cART), a subset of HIV-infected patients who initiate cART develop early clinical progression to AIDS; therefore, some cART initiators are not fully benefitted by cART. Immune activation pre-cART may predict clinical progression...

Contraceptive use and factors associated with postpartum surgical sterilization among HIV-infected women in Pune, India

Post Date:

2015-08-21

Clinical Sites:

BJGMC

Countries:

India

Publication:

Journal of HIV/AIDS & Social Services

The authors desire to better understand contraceptive practices and factors associated with surgical tubal ligation (STL) among HIV-infected women. Secondary data were obtained from HIV-infected women enrolled in a National Institutes of Health–funded clinical trial assessing the efficacy of...

Effectiveness of peer support on care engagement and preventive care intervention utilization among pre-antiretroviral therapy, HIV-infected adults in Rakai, Uganda: a randomized trial

Post Date:

2015-08-14

Countries:

Uganda

Publication:

AIDS and Behavior

442 pre-ART, HIV-infected adults were randomized to peer support consisting of structured home visits to promote clinic attendance and preventive care intervention use or standard of care. At baseline, 62 % reported previously visiting an HIV clinic, 45 % reported taking cotrimoxazole prophylaxis,...

Mobile Health and Behavioral PMTCT Intervention among Community Health Workers Improves Exclusive Breastfeeding and Early Infant Diagnosis in India: A Cluster Randomized Trial

Post Date:

2018-07-24

Clinical Sites:

BJGMC

Countries:

India

Presentation Location:

Amsterdam, The Netherlands

Event & Convener:

AIDS 2018, International AIDS Society

Tablet-based HIV treatment resources & training community health workers to prevent mother-to-child transmission.

Inflammation in HIV-Infected Pregnant Women is Associated with Pre-term Birth

Post Date:

2018-03-07

Clinical Sites:

BJGMC

Countries:

India

Presentation Location:

Boston, MA

Event & Convener:

CROI 2018

Poster Presentation. Shivakoti R, Gupte N, Kumar NP, Kulkarni V, Balasubramanian U, Bhosale R, Sambarey P, Kinikar A, Bharadwaj R, Patil S, Inamdar S, Suryavanshi N, Babu S, Bollinger R, Gupta A

High Burden of Genital TB Among Women with Infertility in India - Need for an Intensified Approach

Post Date:

2017-10-13

Clinical Sites:

BJGMC

Presentation Location:

Guadalajara, Mexico

Event & Convener:

48th Annual Union World Conference of Lung Health

Fogarty Scholar Poster Presentation. Naik SN , Chandanwale A, Joshi S, Mave V, Dhumal G, DeLuca A, Gupta A, Bollinger R

A Study to Compare Efficacy of Oral High Dose Rifampicin with Standard Dose Rifampicin in Tuberculous Meningitis

Post Date:

2017-10-13

Clinical Sites:

BJGMC

Presentation Location:

Guadalajara, Mexico

Event & Convener:

48th Annual Union World Conference of Lung Health

Fogarty Scholar Poster Presentation: Basavaraj A , Avhad A, Kadam D

Prevalence of Vitamin D Deficiency among Indian Children with Tuberculosis and Age- and Sex-matched Controls

Post Date:

2017-10-13

Clinical Sites:

BJGMC

Presentation Location:

Guadalajara, Mexico

Event & Convener:

48th Annual Union World Conference of Lung Health

Fogarty Scholar Presentation. Kinikar A , Chandanwale A, Dixit S, Jubilus J, Jain S, Bharadwaj R, Mave V, Gupte N, DeLuca A, Gupta A, Bollinger RC

Delays and Barriers to Early Treatment Initiation for Childhood Tuberculosis in India

Post Date:

2017-10-13

Clinical Sites:

BJGMC

Presentation Location:

Guadalajara, Mexico

Event & Convener:

48th Annual Union World Conference of Lung Health

Fogarty Scholar Poster Presentation. Valvi C , Chandanwale A, Khadse A, Kulkarni R, Kadam D, Dhumal G, Bollinger RC, Deluca A

Barriers to Contact Screening and Isoniazid Preventive Therapy among Pediatric Contacts of Adults with Smear-positive Tuberculosis

Post Date:

2017-10-12

Clinical Sites:

BJGMC

Presentation Location:

Guadalajara, Mexico

Event & Convener:

48th Annual Union World Conference of Lung Health

Fogarty Scholar Abstract Presentation. Belgaumkar V , Chandanwale A, Valvi C, Khadse S, Jain D, Dhumal G, Bollinger RC, Deluca A

High Burden of Genital TB Among Women with Infertility in India: Need for An Intensified Approach

Post Date:

2017-10-11

Countries:

India

Presentation Location:

Guadalajara, Mexico

Event & Convener:

The 48th Union World Conference on Lung Health

Poster Presentation. Shilpa Naik, Ajay Chandanwale, Vidya Mave, Pradip Sambarey, Gauri Dhumal , Andrea DeLuca, Amita Gupta, Robert Bollinger.

Lack of TB Knowledge among TST positive Household Contacts of Pulmonary Cases: A Missed Opportunity

Post Date:

2017-10-11

Countries:

India

Presentation Location:

Guadalajara, Mexico

Event & Convener:

The 48th Union World Conference on Lung Health

Oral Presentation. Andrea DeLuca, Gauri Dhumal , Mandar Paradkar, Nishi Suryavanshi, Vidya Mave, Rewa Kohli, Shrivijay Shivakumar, Amita Gupta.

Delays and Barriers to Early Treatment Initiation in Childhood Tuberculosis in India

Post Date:

2017-10-11

Countries:

India

Presentation Location:

Guadalajara, Mexico

Event & Convener:

The 48th Union World Conference on Lung Health

Poster Presentation. Valvi C, Chandanwale A, Khadse S, Kulkarni R, Kadam D, Dhumal G , Deluca A, Bollinger RC.

High Burden of Diabetes and Prediabetes among Adult Household Contacts of India

Post Date:

2017-09-13

Clinical Sites:

BJGMC

NIRT

Countries:

India

Presentation Location:

Rio De Janiero, Brazil

Event & Convener:

RePORT International Conference, RICC

Poster Presentation. Shivakumar SVBY , Chandrasekaran P, Kumar AJMV, Paradkar M, Dhanasekaran K, Suryavanshi N, Thomas B, Kohli R, Thiruvengadam K, Kulkarni V, Hannah LE, Sivaramakrishnan GN, Pradhan N, Dolla C, Gupte A, Ramachandran G, DeLuca A, Meshram S, Bhardawaj R, Bollinger RC, Golub J,...

How Americans Benefit from Global Health Research

Post Date:

2017-05-25

Countries:

India

Presentation Location:

Washington, DC

Event & Convener:

The Fogarty International Center: How Americans Benefit from Global Health Research Webinar, Research!America

Invited presenter. Live webinar with NIH Fogarty Director Roger Glass, and Johns Hopkins Desmond M. Tutu Professor of Public Health and Human Rights Chris Beyrer.

Outreach Workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) Programme in India: Challenges and Opportunities

Post Date:

2016-07-21

Clinical Sites:

BJGMC

Countries:

India

Presentation Location:

Durban, South Africa

Event & Convener:

21st Annual International AIDS Conference (AIDS 2016)

Abstract Presentation. Suryavanshi N , Mave V, Kadam A, Kanade S, Sivalenka S, Sampath K, Harve P, Gupta RS, Hegde A, McKenzie-White J, Gupte N, Gupta A, Bollinger RC, Shankar AV.

High TB Risk in HIV-Positive Patients on Second line Antiretrovirals in Pune, India

Post Date:

2016-02-24

Countries:

India

Presentation Location:

Boston, MA

Event & Convener:

Conference on Retroviruses and Opportunistic Infections 2016

Poster Presentation: TB and Antiretroviral Therapy. Authors: Mave V , Kadam D, Salvi S, Basavaraj A, Joshi S, Chandanwale A, Gupte N, Bollinger RC, Gupta A.

TB Risk Perceptions Among Medical Residents at a Tertiary Care Center in India

Post Date:

2015-12-06

Countries:

India

Presentation Location:

Cape Town, South Africa

Event & Convener:

46th Union World Conference on Lung Health. International Union for Tuberculosis and Lung Disease.

Oral Abstract. Session: The Wide Swath of Vulnerable Populations. Pardeshi G , Parande M, Kadam D, Chandanwale A, Deluca A, Bollinger R, Farley J, Suryavanshi N.

Incidence and Risk Factors for TB among HIV+ Children in India

Post Date:

2015-12-05

Clinical Sites:

BJGMC

Countries:

India

Presentation Location:

Cape Town, South Africa

Event & Convener:

The 46th Union World Conference on Lung Health

Poster Discussion. Session: TART: TB Risk and Impact of ART. Authors: Kinikar AA , DeLuca A, Gupte N, Kadam DB, Khadse S, Chandanwale A, Gupta A, Bollinger R.

TB Outbreak among Health Care Workers and Trainees in a Tertiary-care Hospital in Pune, India

Post Date:

2015-12-05

Clinical Sites:

BJGMC

Countries:

India

Presentation Location:

Cape Town, South Africa

Event & Convener:

46th Union World Conference on Lung Health

E-Poster Discussion. Session: Preventing Infection and Transmission of TB in Health Facilities and the Community. Authors: Basavaraj A , Patil A, Kadam DB, Chandanwale A, Jain D, DeLuca A, Mave V, Bollinger R.

Risk Factors for Unfavorable Treatment Outcomes in DOTs-treated Pediatric TB Patients

Post Date:

2015-12-04

Clinical Sites:

BJGMC

Countries:

India

Presentation Location:

Cape Town, South Africa

Event & Convener:

The 46th Union World Conference on Lung Health

Poster Discussion. Session: TB in Children: Epidemiology–I. Authors: Shelke S, Bollinger R, Chandanwale A, DeLuca A, Gupta A, Gupte N, Adhav PS, Kadam DB.

Utility of GeneXpert for Diagnosis of Rifampicin-resistant Extra-pulmonary TB—A Retrospective Review of 70 Cases, SGH, Pune, India

Post Date:

2015-12-04

Clinical Sites:

BJGMC

Countries:

India

Presentation Location:

Cape Town, South Africa

Event & Convener:

The 46th Union World Conference on Lung Health

Poster Session. TB Diagnostic Challenges: Molecular and Other Techniques. Authors: Girish S, Dharmashle S, Desai S, Kagal A, Bharadwaj R, Chandanwale A, Lokhande R, Kadam DB, DeLuca A, Gupte N, Jain D, Gupta A, Bollinger R, Mave V.

Developing a Validated Tool to Assess Internal Medicine and Infectious Disease Trainees’ Ability to Obtain and Interpret TB Diagnostics

Post Date:

2015-10-11

Presentation Location:

San Diego, CA

Event & Convener:

ID Week 2015

Presentation. Chida N, Gupta A, Bollinger B, Melia M.

Geeta Shrikar Pardeshi, MD

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

I have led research projects related to Reproductive and Child Health, Sanitation and Infectious diseases. As part of the BJGMC JHU Fogarty training program in HIV-TB, I have research interest in TB epidemiology. I am interested in studying the association of co-morbidities with clinical presentation and treatment outcomes in tuberculosis.

Sunita Girish, PhD

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

Education : Ph.D, Pune University, 2005 (Medical Biochemistry) title “Antioxidant Status in Leprosy.” Overview : How to improve health systems to combat various infectious diseases like Leprosy, Tuberculosis and HIV in developing countries, is a research and policy issue that affects many aspects of public health. My research interests include further to understand molecular level changes in cystic fibrosis which is under diagnosed .My interests also involve innovations in molecular techniques dealing with infectious diseases, help governments in developing countries to improve and modify...

Sangita Shelke, MD

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

Indeed TB is a social disease with so many social problems especially the women suffering from TB/HIV undergoes a pathetic life situation. Women are silent suffers, of both HIV and TB in male dominated society of India. My ultimate desire is if I can make a difference in the lives of these silent suffers.

Dr. Smita Deshpande

BJGMC-JHU Fogarty HIV-TB Program Trainee

My research interests have been: Rapid diagnostic methods for Acute pyogenic meningitis, Diagnosis of enteric fever , Role of Methicillin resistance Staph aureus in infections, Molecular diagnosis of Leptospirosis, Rapid diagnosis of MDR-TB by REMA ( Resasurine Micro titre Plate Assay)and by Line Probe Assay.

Dr. Chhaya Valvi

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

Dr. Chhaya Valvi has completed her undergraduate and postgraduate medical education from the premier institute of Seth G.S. Medical College, Mumbai, India. She was awarded the prestigious Dr. Palekar prize as she ranked first among the candidates for M.D. exam.

Dr. Vasudha Belgaumkar

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

Dr.Vasudha has completed her undergraduate medical education from S.B.H. Government Medical College, Dhule,Maharashtra .A meritorious student throughout, she topped her first and final year University examinations. She is presently working as Associate Professor of Dermatology at B.J. Government Medical College, Pune. Having completed her post-graduation in Dermatology, Venereology (including HIV) and Leprology from this premier institute, she has acquired clinical skills as well as an affinity for research.

Rahul Lokhande, MD

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

He is Unit In charge at B J Government Medical college and Sassoon Hospital Pune . He has special Interest in Bronchoscopy and Respiratory Intensive Care Unit of Sassoon Hospital.

Dr. Shilpa Naik

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

I am working as an Associate Professor & Unit Incharge since 2009 in the Department of Obstetrics & Gynecology at B.J.Govt Medical College & Sassoon General Hospitals Pune. I have been managing High Risk Obstetrics and has keen interest in Critical Care Obstetrics.

Akshay Gupte, PhD, MBBS, MSPH

Junior Investigator

Akshay Gupte is a junior investigator trained in medicine, clinical research, and global health. He recently completed his doctoral training in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health (JHSPH). His research interests include exploring approaches to host directed adjuvant therapies in tuberculosis (TB) and studying the impact of TB and HIV on lung health of populations. Akshay is leading an Indo-US collaborative study aimed at exploring the impact of TB disease; alone and in combination with smoking, air pollution, HIV and diabetes mellitus...

Jeff Tornheim, MD, MPH

Infectious Disease Fellow

Baltimore, Maryland

Jeff Tornheim, MD, MPH, is a clinical fellow in the Division of Infectious Disease here at Johns Hopkins University School of Medicine. After completing undergraduate studies in International Development and Economics at Brandeis University he moved to East Africa where he engaged in health system strengthening for returning refugees to South Sudan and worked with the Centers for Disease Control and Prevention (CDC) on the epidemiology of pneumonia and diarrhea in Western Kenya. He completed a joint MD/MPH at Mount Sinai School of Medicine, with his thesis evaluating the impact of water...

Aarti Avinash Kinikar, MD

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

Education : MBBS (1984); DCH (1988); MD-Paediatrics (1988), DNB-Paediatrics (2003); MRCP-UK (1995). Medical Education- Grant Medical College – Mumbai University, India.

Amit Kale, MS

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

I am working as associate professor in orthopedics. Currently, I am conducting various drug trials for rheumatoid arthritis.

Anita Basavaraj, MD

BJGMC-JHU Fogarty HIV-TB Program Trainee

Pune, India

Dr Anita Basavaraj has done her MBBS from Nagpur University with Honors in Surgery (1987). Thereafter she did her MD in Medicine (1990) and her Diplomat of National Board (D.N.B.) in 1992.She has done her post graduate Diploma in geriatric Medicine (P.G.D.G.M.) winning the university Gold Medal by virtue of standing first in the country (2012), which is a distant education venture run by Indira Gandhi National Open University (IGNOU).

National Institutes of Health: Fogarty International Center Advisory Board

Post Date:

2017-10-15

Advisory Board Member, 2017, Bollinger

Johns Hopkins University School of Nursing Center for Global Initiatives

Post Date:

2014-01-01

Bob Bollinger, Advisory Board Member, 2014–Present

US Institute of Medicine Public-Private Partnerships Forum for Global Health and Safety

Post Date:

2014-01-01

Bob Bollinger, Member, 2014–Present.

Johns Hopkins University Faculty Advisory Committee on International Activities (FACIA)

Post Date:

2013-01-01

Bob Bollinger, Member 2013–Present.

Centro SOL (Salud/Health and Opportunity for Latinos)

Post Date:

2013-01-01

Bob Bollinger, Advisory Board Member, 2013–Present. Johns Hopkins Bayview.

CUGH Scientific Program Advisory Committee

Post Date:

2013-01-01

Bob Bollinger, Member, 2013–Present. Consortium of Universities for Global Health’s Annual Conference.

2nd GETHealth Summit (Global Education and Technology)

Post Date:

2013-01-01

Bob Bollinger, Abstract Reviewer.

Center for AIDS Research Leadership Committee

Post Date:

2013-01-01

Bob Bollinger, Member, 2014–Present.

Johns Hopkins InHealth

Post Date:

2012-01-01

Bob Bollinger, Member. Johns Hopkins Bloomberg School of Public Health.

JHU Global mHealth Initiative

Post Date:

2011-01-01

Bob Bollinger, Member. Johns Hopkins Bloomberg School of Public Health

iHeed Institute

Post Date:

2011-01-01

Bob Bollinger, Member, Advisory Board, 2011–Present,

US-India Infectious Diseases Working Group

Post Date:

2011-01-01

Bob Bollinger, Member, 2011–Present. US-India Health Initiative.

Johns Hopkins Infectious Diseases Fellowship Recruitment and Selection Committee

Post Date:

2009-01-01

Bob Bollinger, Member 2009–Present.

Consortium of Academic Centers Committed to Cross-Disciplinary Global Health Training and Mentorship

Post Date:

2008-01-01

Bob Bollinger, Member, Consortium Working Group.

Great Lakes Restoration

Post Date:

2008-01-01

Bob Bollinger, Member, Board of Directors, 2008–Present. "Building the Peace" Eastern Africa

Clinical Management Committee, HPTN 052

Post Date:

2007-01-01

Bob Bollinger, Member, 2007–2010. HIV Prevention Trials Network Study HPTN 052, “A Randomized Trial to Evaluate the Effectiveness of ART plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples

Cross Network Immunology Quality Assurance Working Group

Post Date:

2007-01-01

Bob Bollinger, Member, 2007–2008. HIV Prevention Trials Network Laboratory, DAIDS.

IMPAACT Primary Therapy Scientific Committee

Post Date:

2007-01-01

Bob Bollinger, Member, 2007-2010

IMPAACT Performance Evaluation Resource Committee

Post Date:

2007-01-01

Bob Bollinger, Member, 2007–2011.

IMPAACT Protocol Development and Monitoring Committee

Post Date:

2007-01-01

Bob Bollinger, Member, 2007–2008.

Infectious Diseases Can Be Tackled, Here are 3 Solutions

Post Date:

2018-05-09

Source:

The Hill

Bob Bollinger: Quick delivery of care to sick patients eases the human impact and lowers the cost of disease.

TB medication adherence rates up, thanks to smartphone app

Post Date:

2018-03-02

Source:

YourCentralValley.com (Fresno, CA)

Emocha's app is helping tuberculosis patients in Fresno County stick to their treatment plans.

2017 Year in Review

Post Date:

2018-02-19

What a year! Our 2017 Year In Review outlines the most ambitious 365 days we’ve had to date.

WHO sets disease priorities for 2018; Tuberculosis once again not included

Post Date:

2018-02-15

Source:

Contagion Live: Infectious Diseases Today

CCGHE Director Bob Bollinger weighs in on WHO's priority pathogens for 2018.

Uniting for a Healthier India

Post Date:

2018-02-14

"The Indo-US clinical research & education partnership started with a single NIH grant to study maternal-infant HIV transmission." Now with 76 studies underway, this short film chronicles the history & impact of our work in India.

In-Depth: How digital health technologies can help the United States address the opioid epidemic

Post Date:

2018-01-05

Source:

MobiHealthNews

Bob Bollinger interviewed about utility of mobile health in keeping patients connected to care.

Notes from the Field: Use of Asynchronous Video Directly Observed Therapy for Treatment of Tuberculosis and Latent Tuberculosis Infection in a Long-Term–Care Facility ― Puerto Rico, 2016–2017

Post Date:

2017-12-22

Source:

Morbidity and Mortality Weekly Report

emocha's video Directly Observed Therapy is highlighted in this report.

Notes from the Field--Tuberculosis Control Activities After Hurricane Harvey--Texas, 2017

Post Date:

2017-12-15

Source:

Morbidity and Mortality Weekly Report

emocha's video Directly Observed Therapy helped officials maintain continuity of care for TB patients following Hurricane Harvey.

Upstarts: A Better Blood Test?

Post Date:

2017-12-15

Source:

JHU Engineering Impact

The miLAB handheld diagnostic project led by Dr. Bob Bollinger is the feature of this report.

Celebrating Johns Hopkins Medicine's impact in India

Post Date:

2017-12-13

Source:

The Campaign for Johns Hopkins Medicine

In 4 years, the CCGHE has tripled its capacity for conducting research on grave health threats, thanks to strong philanthropic support.

4 ways that telemedicine can address the opioid crisis

Post Date:

2017-12-01

Source:

The Hill

CCGHE Director Dr. Bob Bollinger describes the utility of telemedicine in this opinion article in The Hill.

Technology could help opioid addicts in rural America, but a federal rule needs changing

Post Date:

2017-11-08

Source:

McClatchy News

CCGHE's Dr. Bob Bollinger discusses the utility of emocha in treating patients in remote areas.

Tech designed for Africa helps US fight disease, save money

Post Date:

2017-10-12

Source:

Global Health Matters

Dr. Bob Bollinger talks with the NIH Fogarty Center about development of the emocha mobile health platform.

Bollinger tapped for Fogarty International Center Advisory Board

Post Date:

2017-10-12

Source:

Global Health Matters

CCGHE Director joins the Fogarty International Advisory Board, which provides strategic guidance on policies and programs

Emocha Mobile Health expands to opioid addiction treatment

Post Date:

2017-06-23

Source:

Baltimore Sun

Baltimore Sun: emocha received award to expand miDOT capabilities to help care providers treat opioid addiction.

emocha is looking to help treat opioid addiction

Post Date:

2017-06-16

Source:

Technical.ly Baltimore

emocha received a $1.7 million grant from the National Institute on Drug Abuse to complete the research studies ahead of its commercial release. The technology will be used in clinic-based treatment, with observation of take-home being a next step. The grant will help the startup validate the...

Emocha launches pilot to help recovering opioid addicts

Post Date:

2017-06-15

Source:

Baltimore Business Journal

Emocha will be piloting its platform in partnership with two opioid recovery clinics based at the University of Washington in Seattle and Boston University.

Company tests mobile health for tuberculosis treatment

Post Date:

2017-05-23

Source:

NIH: News and Events

Preliminary data show 93% treatment adherence using video observation, with savings of more than $1,000 per TB patient over 6 months

Fogarty International Center, a linchpin of global health research

Post Date:

2017-05-17

Source:

JAMA

Bob Bollinger weighs in on NIH’s Fogarty Program & the strategic benefits the program offers for US disease surveillance.

2017 Directors' Statement

Post Date:

2017-01-31

A New Decade of Global Health Impact The CCGHE recently marked its 10-year anniversary, and it’s an occasion that affords an opportunity to reflect on the progress we’ve made so far, and envision what lies ahead. We are encouraged by the changes we’ve seen in health outcomes for people living with...

You are here

Bob Bollinger, MD, MPH

Pages

Pages

Pages

Pages

Pages

Center for Clinical Global Health Education Johns Hopkins School of Medicine

Center for Clinical Global Health Education
Johns Hopkins School of Medicine